These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 16103264)

  • 1. Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats.
    Pilz B; Shagdarsuren E; Wellner M; Fiebeler A; Dechend R; Gratze P; Meiners S; Feldman DL; Webb RL; Garrelds IM; Jan Danser AH; Luft FC; Müller DN
    Hypertension; 2005 Sep; 46(3):569-76. PubMed ID: 16103264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The direct renin inhibitor aliskiren improves vascular remodelling in transgenic rats harbouring human renin and angiotensinogen genes.
    Savoia C; Arrabito E; Parente R; Sada L; Madaro L; Nicoletti C; Zezza L; Alonzo A; Rubattu S; Michelini S; Muller DN; Volpe M
    Clin Sci (Lond); 2013 Aug; 125(4):183-9. PubMed ID: 23438195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary n-3 polyunsaturated fatty acids and direct renin inhibition improve electrical remodeling in a model of high human renin hypertension.
    Fischer R; Dechend R; Qadri F; Markovic M; Feldt S; Herse F; Park JK; Gapelyuk A; Schwarz I; Zacharzowsky UB; Plehm R; Safak E; Heuser A; Schirdewan A; Luft FC; Schunck WH; Muller DN
    Hypertension; 2008 Feb; 51(2):540-6. PubMed ID: 18158339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Add-on aliskiren elicits stronger renoprotection than high-dose valsartan in type 2 diabetic KKAy mice that do not respond to low-dose valsartan.
    Lei B; Nakano D; Fan YY; Kitada K; Hitomi H; Kobori H; Mori H; Masaki T; Nishiyama A
    J Pharmacol Sci; 2012; 119(2):131-8. PubMed ID: 22673148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aliskiren improves left ventricular dysfunction and reduces cardiac dilation in Syrian cardiomyopathic hamsters.
    Crespo MJ; Cangiano JL; Altieri PI; Escobales N
    J Cardiovasc Pharmacol; 2012 Jun; 59(6):547-52. PubMed ID: 22370958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aliskiren, a novel, orally effective renin inhibitor, lowers blood pressure in marmosets and spontaneously hypertensive rats.
    Wood JM; Schnell CR; Cumin F; Menard J; Webb RL
    J Hypertens; 2005 Feb; 23(2):417-26. PubMed ID: 15662231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension.
    Moniwa N; Varagic J; Ahmad S; VonCannon JL; Simington SW; Wang H; Groban L; Brosnihan KB; Nagata S; Kato J; Kitamura K; Gomez RA; Lopez ML; Ferrario CM
    Hypertension; 2013 Feb; 61(2):417-24. PubMed ID: 23232645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial cardiac effects of the renin inhibitor aliskiren in spontaneously hypertensive rats.
    van Esch JH; Moltzer E; van Veghel R; Garrelds IM; Leijten F; Bouhuizen AM; Danser AH
    J Hypertens; 2010 Oct; 28(10):2145-55. PubMed ID: 20625318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.
    Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Tokutomi Y; Matsuba S; Nako H; Nakagata N; Kaneko T; Ogawa H; Kim-Mitsuyama S
    Hypertension; 2009 Sep; 54(3):633-8. PubMed ID: 19597038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte infiltration and adhesion molecules in a rat model of high human renin hypertension.
    Mervaala EM; Müller DN; Park JK; Schmidt F; Löhn M; Breu V; Dragun D; Ganten D; Haller H; Luft FC
    Hypertension; 1999 Jan; 33(1 Pt 2):389-95. PubMed ID: 9931135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The direct renin inhibitor aliskiren localizes and persists in rat kidneys.
    Feldman DL; Jin L; Xuan H; Persohn E; Zhou W; Schuetz H; Park JK; Muller DN; Luft FC
    Am J Physiol Renal Physiol; 2013 Dec; 305(11):F1593-602. PubMed ID: 23926182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of the blood pressure circadian rhythm by direct renin inhibition and blockade of angiotensin II receptors in mRen2.Lewis hypertensive rats.
    Moniwa N; Varagic J; Ahmad S; VonCannon JL; Ferrario CM
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):15-29. PubMed ID: 22222314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects.
    Park JK; Müller DN; Mervaala EM; Dechend R; Fiebeler A; Schmidt F; Bieringer M; Schäfer O; Lindschau C; Schneider W; Ganten D; Luft FC; Haller H
    Kidney Int; 2000 Oct; 58(4):1420-30. PubMed ID: 11012877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclosporin A protects against angiotensin II-induced end-organ damage in double transgenic rats harboring human renin and angiotensinogen genes.
    Mervaala E; Müller DN; Park JK; Dechend R; Schmidt F; Fiebeler A; Bieringer M; Breu V; Ganten D; Haller H; Luft FC
    Hypertension; 2000 Jan; 35(1 Pt 2):360-6. PubMed ID: 10642325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure-independent effects in rats with human renin and angiotensinogen genes.
    Mervaala E; Müller DN; Schmidt F; Park JK; Gross V; Bader M; Breu V; Ganten D; Haller H; Luft FC
    Hypertension; 2000 Feb; 35(2):587-94. PubMed ID: 10679502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone synthase inhibitor ameliorates angiotensin II-induced organ damage.
    Fiebeler A; Nussberger J; Shagdarsuren E; Rong S; Hilfenhaus G; Al-Saadi N; Dechend R; Wellner M; Meiners S; Maser-Gluth C; Jeng AY; Webb RL; Luft FC; Muller DN
    Circulation; 2005 Jun; 111(23):3087-94. PubMed ID: 15939810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage.
    Muller DN; Mervaala EM; Schmidt F; Park JK; Dechend R; Genersch E; Breu V; Löffler BM; Ganten D; Schneider W; Haller H; Luft FC
    Hypertension; 2000 Aug; 36(2):282-90. PubMed ID: 10948091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic demonstration of the synergistic effects of a combination of the renin inhibitor aliskiren and the AT1 receptor antagonist valsartan on the angiotensin II-renin feedback interruption.
    Azizi M; Ménard J; Bissery A; Guyenne TT; Bura-Rivière A; Vaidyanathan S; Camisasca RP
    J Am Soc Nephrol; 2004 Dec; 15(12):3126-33. PubMed ID: 15579516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal and hemodynamic effects of aliskiren and valsartan and their combination in sodium-replete normotensive individuals.
    Azizi M; Ménard J; Bissery A; Guyene TT; Bura-Rivière A
    Clin J Am Soc Nephrol; 2007 Sep; 2(5):947-55. PubMed ID: 17702736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.
    Solomon SD; Appelbaum E; Manning WJ; Verma A; Berglund T; Lukashevich V; Cherif Papst C; Smith BA; Dahlöf B;
    Circulation; 2009 Feb; 119(4):530-7. PubMed ID: 19153265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.